Kintor shares plunge after hair-loss drug flops in clinical trials
The company’s drug has failed to show a significant hair-boosting effect in Phase III trials, dashing investors’ hopes for a ground-breaking treatment for baldness Key Takeaways: The disappointing test results…
Recent Articles
RELATED ARTICLES
-
Kintor Pharma eyes regeneration with over-the-counter cosmetic treatments
9939.HK -
Akeso marks profit milestone with swift rights issue
9926.HK
-
Clinical trials come up short again for Alphamab Oncology
9966.HK
-
Test results for new cancer drug take Akeso investors on wild ride
9926.HK
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK
